J. Clin. Med. 2013, 2(4), 201-213; doi:10.3390/jcm2040201
Review

Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases

Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital, 371, Avenue du Doyen Gaston Giraud, Montpellier 34295, France
* Author to whom correspondence should be addressed.
Received: 16 August 2013; in revised form: 10 September 2013 / Accepted: 27 September 2013 / Published: 23 October 2013
(This article belongs to the Special Issue Frontiers in Stem Cell Treatments)
PDF Full-text Download PDF Full-Text [441 KB, uploaded 23 October 2013 14:23 CEST]
Abstract: Multipotent mesenchymal stromal cells or mesenchymal stem cells (MSCs) are adult stem cells exhibiting functional properties that have opened the way for cell-based clinical therapies. MSCs have been reported to exhibit immunosuppressive as well as healing properties, improving angiogenesis and preventing apoptosis or fibrosis through the secretion of paracrine mediators. This review summarizes recent progress on the clinical application of stem cells therapy in some inflammatory and degenerative rheumatic diseases. To date, most of the available data have been obtained in preclinical models and clinical efficacy needs to be evaluated through controlled randomized double-blind trials.
Keywords: mesenchymal stem cells; rheumatic diseases; osteoarthritis; rheumatoid arthritis; autoimmune diseases; immune tolerance

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Pers, Y.-M.; Jorgensen, C. Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases. J. Clin. Med. 2013, 2, 201-213.

AMA Style

Pers Y-M, Jorgensen C. Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases. Journal of Clinical Medicine. 2013; 2(4):201-213.

Chicago/Turabian Style

Pers, Yves-Marie; Jorgensen, Christian. 2013. "Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases." J. Clin. Med. 2, no. 4: 201-213.

J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert